Bulletin
Investor Alert

New York Markets Open in:

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Jul 2, 2020, 5:45 a.m.

/zigman2/quotes/209129655/composite

$

7.29

Change

+0.28 +3.99%

Volume

Volume 1,328

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 7.01

$ 7.01

Change

-0.10 -1.41%

Day low

Day high

$7.01

$7.46

Open

52 week low

52 week high

$2.43

$48.48

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
4,009   Derivative/Non-derivative trans. at $0 per share. 0
06/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
06/17/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.04 per share. 937,994
06/16/2020 Brendan Kennedy
President and CEO; Director
116,666   Disposition at $8.34 per share. 972,994
06/05/2020 Michael Shtender-Auerbach
Director
10,475   0
06/05/2020 Michael Shtender-Auerbach
Director
210,710   0
06/05/2020 Michael Shtender-Auerbach
Director
57,159   0
06/05/2020 Michael Shtender-Auerbach
Director
538,706   0
06/01/2020 Maryscott Greenwood
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Rebekah Dopp
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
06/01/2020 Christine Thompson St. Clare
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Michael Shtender-Auerbach
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Maryscott Greenwood
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Rebekah Dopp
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/28/2020 Christine Thompson St. Clare
Director
7,371   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2020 Michael Shtender-Auerbach
Director
125,580   Disposition at $7.38 per share. 926,780
05/01/2020 Michael Shtender-Auerbach
Director
95,131   Disposition at $7.38 per share. 702,066
05/01/2020 Michael Shtender-Auerbach
Director
18,290   Derivative/Non-derivative trans. at $0.19 per share. 3,475
05/01/2020 Michael Shtender-Auerbach
Director
107,290   Derivative/Non-derivative trans. at $0.19 per share. 20,385
04/06/2020 Michael Shtender-Auerbach
Director
1,069   0
04/06/2020 Michael Shtender-Auerbach
Director
6,822   0
04/06/2020 Michael Shtender-Auerbach
Director
425,235   0
04/06/2020 Michael Shtender-Auerbach
Director
166,326   0
04/01/2020 Brendan Kennedy
President and CEO; Director
11,415   Derivative/Non-derivative trans. at $5.9 per share. 67,348
04/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2020 Michael Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
16,072   Derivative/Non-derivative trans. at $2.47 per share. 39,697
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
30,024   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
15 Purchases
8 Sales
455,360
1,588,319
Last 6 months
23 Purchases
14 Sales
647,258
1,815,806
Last 12 months
43 Purchases
23 Sales
4,583,056
2,072,062

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Mr. Cuba Flowers
Chief Information Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Ms. Kristina Adamski
Executive Vice President-Corporate Affairs
Mr. Mark Castaneda
Head-Strategic Business Development
Mr. John Andonoff
SVP-Global Medical Sales Development
Mr. Andrew Pucher
Chief Corporate Development Officer
Mr. Edward Wood Pastorius
Chief Revenue Officer
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.